Elahere 100 MG/20 ML vial 20ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21EJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,079
Award facts
- Contract value 100% obligated
- $28,078.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,078.86 delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of ELAHERE (mirvetuximab soravtansine) 100 mg/20 mL vials. This firm fixed-price contract, with an ultimate completion date of February 13, 2026, was competitively awarded without a set-aside designation. The award will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ELAHERE is a targeted cancer therapy used in the treatment of ovarian cancer, reflecting the Defense Logistics Agency Medical Supply Chain's continued procurement of specialized pharmaceutical products to support military healthcare systems.
This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s large Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 31, 2031. This comprehensive IDC vehicle enables Cencora and its subsidiaries to supply a broad portfolio of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities—to support military treatment facilities and federal healthcare programs globally. AmerisourceBergen's consistent performance on competitive federal contracts demonstrates its capability to fulfill critical medical supply requirements for the Department of Defense healthcare enterprise.
Quick answers
Who was awarded contract SPE2DR26F21EJ?
SPE2DR26F21EJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F21EJ worth?
The government has obligated $28,079 on SPE2DR26F21EJ.
Is contract SPE2DR26F21EJ an order under another contract?
Yes. SPE2DR26F21EJ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21EJ competed?
The extent of competition for SPE2DR26F21EJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award